These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17285745)

  • 1. Physicochemical characterization of the freezing behavior of mannitol-human serum albumin formulations.
    Hawe A; Friess W
    AAPS PharmSciTech; 2006; 7(4):94. PubMed ID: 17285745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of freezing procedure and annealing on the physico-chemical properties and the formation of mannitol hydrate in mannitol-sucrose-NaCl formulations.
    Hawe A; Friess W
    Eur J Pharm Biopharm; 2006 Nov; 64(3):316-25. PubMed ID: 16875806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physico-chemical lyophilization behavior of mannitol, human serum albumin formulations.
    Hawe A; Friess W
    Eur J Pharm Sci; 2006 Jun; 28(3):224-32. PubMed ID: 16580820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective inhibition of mannitol crystallization in frozen solutions by sodium chloride.
    Telang C; Yu L; Suryanarayanan R
    Pharm Res; 2003 Apr; 20(4):660-7. PubMed ID: 12739776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Freeze-drying of mannitol-trehalose-sodium chloride-based formulations: the impact of annealing on dry layer resistance to mass transfer and cake structure.
    Lu X; Pikal MJ
    Pharm Dev Technol; 2004; 9(1):85-95. PubMed ID: 15000469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannitol/l-Arginine-Based Formulation Systems for Freeze Drying of Protein Pharmaceuticals: Effect of the l-Arginine Counter Ion and Formulation Composition on the Formulation Properties and the Physical State of Mannitol.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2016 Oct; 105(10):3123-3135. PubMed ID: 27506270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallization of mannitol below Tg' during freeze-drying in binary and ternary aqueous systems.
    Pyne A; Surana R; Suryanarayanan R
    Pharm Res; 2002 Jun; 19(6):901-8. PubMed ID: 12134964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Excipient Interactions on the State of the Freeze-Concentrate and Protein Stability.
    Jena S; Horn J; Suryanarayanan R; Friess W; Aksan A
    Pharm Res; 2017 Feb; 34(2):462-478. PubMed ID: 27981449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
    Anhorn MG; Mahler HC; Langer K
    Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of freeze/thaw-related quality attributes of a liquid biopharmaceutical formulation: the role of saccharide excipients.
    Zhou R; Schlam RF; Yin S; Gandhi RB; Adams ML
    PDA J Pharm Sci Technol; 2012; 66(3):221-35. PubMed ID: 22634588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulations of sugars with amino acids or mannitol--influence of concentration ratio on the properties of the freeze-concentrate and the lyophilizate.
    Lueckel B; Bodmer D; Helk B; Leuenberger H
    Pharm Dev Technol; 1998 Aug; 3(3):325-36. PubMed ID: 9742553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Through-vial impedance spectroscopy of critical events during the freezing stage of the lyophilization cycle: the example of the impact of sucrose on the crystallization of mannitol.
    Arshad MS; Smith G; Polygalov E; Ermolina I
    Eur J Pharm Biopharm; 2014 Aug; 87(3):598-605. PubMed ID: 24825125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cations and anions on glass transition temperatures in excipient solutions.
    Nesarikar VV; Nassar MN
    Pharm Dev Technol; 2007; 12(3):259-64. PubMed ID: 17613889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization of rasburicase and physico-chemical characterization of the resulting injectable formulation.
    Bayol A; Breul T; Dupin P; Menegotto J; Aleman C; Duplaa H; Faure P; Bonnet MC; Bauer M
    Drug Dev Ind Pharm; 2004 Sep; 30(8):877-89. PubMed ID: 15521333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miscibility as a factor for component crystallization in multisolute frozen solutions.
    Izutsu KI; Shibata H; Yoshida H; Goda Y
    J Pharm Sci; 2014 Jul; 103(7):2139-2146. PubMed ID: 24903048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of subambient differential scanning calorimetry to monitor the frozen-state behavior of blends of excipients for freeze-drying.
    Martini A; Kume S; Crivellente M; Artico R
    PDA J Pharm Sci Technol; 1997; 51(2):62-7. PubMed ID: 9146035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutual Influence of Mannitol and Trehalose on Crystallization Behavior in Frozen Solutions.
    Jena S; Suryanarayanan R; Aksan A
    Pharm Res; 2016 Jun; 33(6):1413-25. PubMed ID: 26908047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannitol-sucrose mixtures--versatile formulations for protein lyophilization.
    Johnson RE; Kirchhoff CF; Gaud HT
    J Pharm Sci; 2002 Apr; 91(4):914-22. PubMed ID: 11948529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sugar additives on stability of human serum albumin during vacuum foam drying and storage.
    Hajare AA; More HN; Pisal SS
    Curr Drug Deliv; 2011 Nov; 8(6):678-90. PubMed ID: 22313163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.